# Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR

> **NCT03443518** · PHASE2 · COMPLETED · sponsor: **Dr. Erfan and Bagedo General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Analgesic Adverse Reaction

## Interventions

- **PROCEDURE:** Psoas Compartment Block (PCB)
- **PROCEDURE:** Local Anesthesia infiltration
- **DRUG:** Normal saline 0.9% IV infusion
- **DRUG:** Remifentanil infusion

## Key facts

- **NCT ID:** NCT03443518
- **Lead sponsor:** Dr. Erfan and Bagedo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2018-11-10
- **Final completion:** 2018-12-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03443518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03443518, "Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03443518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*